ZELTIQ Aesthetics (ZLTQ) Tops Q2 EPS by 7c

ZELTIQ Aesthetics (NASDAQ: ZLTQ) reported Q2 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $64.4 million versus the consensus estimate of $57.56 million.

ZELTIQ Aesthetics sees FY2015 revenue of $245-247 million, versus prior guidance of $235-238 million.

Mark Foley, President and Chief Executive Officer, said, "The second quarter of 2015 was an exceptionally strong quarter across all areas of our business. We reported over $64 million in revenue, up 37% year-over-year, driven by strong global system placements, an increase in account utilization and the launch of our CoolSmooth Pro applicator. We are very pleased with our second quarter results and the year-over-year growth we generated, particularly when normalized for the revenue and utilization associated with the launch of our initial CoolSmooth applicator in the second quarter of 2014. This performance has led us to once again increase our full year 2015 revenue guidance to a range of $245 million to $247 million."

Mr. Foley continued, "As our sales and marketing teams broaden the adoption and utilization of CoolSculpting, our R&D team is working diligently to ensure we have a strong pipeline to further enhance our position as the market leader in non-invasive fat reduction and to expand the applicability of our cold-based platform. The recent success we have had with CoolSmooth PRO" and the pending launch of CoolMini" are two examples of our ability to successfully leverage our technology. The CoolSmooth PRO" applicator has received exceptional feedback from physicians and patients who are very pleased with the shorter treatment times due to its ability to deliver colder temperatures. We are also on track to launch CoolMini" during the fourth quarter, designed to treat the submental fat area, or "double chin", and other smaller pockets of fat. Thus far, we have seen very favorable results in our clinical trials as well as excellent outcomes and feedback in our pilot launch in Europe. Of particular note, patients are reporting very high satisfaction following just one or two treatments with little, to no, discomfort or downtime. We are incredibly excited about the significant new market opportunity the submental category provides, as well as its ability to bring new patients into the aesthetic channel. Lastly, we just completed a 3 month brand awareness pilot program across 4 U.S. cities and we are encouraged by the early results. This direct-to-consumer advertising pilot materially increased both the traffic to our website and actual patient treatments in these markets. We believe the ongoing success of our marketing, practice enhancement and brand awareness initiatives, combined with our R&D strategy to leverage our unique, proprietary technology, will lead to sustained high growth and further extend our leadership position in the non-invasive fat reduction category."

For earnings history and earnings-related data on ZELTIQ Aesthetics (ZLTQ) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral